Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317526227> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4317526227 endingPage "142" @default.
- W4317526227 startingPage "140" @default.
- W4317526227 abstract "Introduction: Atypical antipsychotics, such as olanzapine, act on multiple neurotransmitter pathways and produce complex central nervous system effects. Pre-clinical and clinical studies conducted in the past, to study their effects on anxiety, have come up with confusing and contradictory observations. Some studies have even indicated anxiogenic effect of these novel drugs. These observations are significant, because anxiety symptoms are known to be present in about 65% of schizophrenia patients. Any possible anxiogenic effect by one of the extensively used antipsychotic can have adverse impact on these patients. Hence, this study was undertaken with the aim of evaluating olanzapine for its effects on anxiety, in preclinical models. Methods: Rats of either sex weighing between 150 and 300 g were placed into three groups of six each. For 10 days, oral doses of the test drug (olanzapine 2 mg/kg), the control drug (distilled water), and the standard drug (diazepam 1 mg/kg) were given. The animals were taken for the elevated plus maze (EPM) and light dark arena (LDA) screening tests on the 10th day, 1 h after the compounds were administered. Results: Olanzapine treatment significantly reduced the amount of time that animals spent in open arms (p<0.05) of the EPM, and highly lighted compartments (p<0.05) of LDA, as compared to animals receiving control treatment, showing a significant anxiogenic impact. Conclusions: Olanzapine has exhibited potential to produce anxiogenic effect in preclinical models. Hence, it is suggested to use olanzapine with caution in patients of schizophrenia with anxiety symptoms." @default.
- W4317526227 created "2023-01-20" @default.
- W4317526227 creator A5066566340 @default.
- W4317526227 creator A5085574543 @default.
- W4317526227 date "2022-01-07" @default.
- W4317526227 modified "2023-09-27" @default.
- W4317526227 title "ANXIOGENIC EFFECT OF AN ATYPICAL ANTIPSYCHOTIC, OLANZAPINE IN PRE-CLINICAL MODELS" @default.
- W4317526227 cites W1955455475 @default.
- W4317526227 cites W1969452795 @default.
- W4317526227 cites W1975357005 @default.
- W4317526227 cites W2004087971 @default.
- W4317526227 cites W2007868610 @default.
- W4317526227 cites W2035784860 @default.
- W4317526227 cites W2065318828 @default.
- W4317526227 cites W2118826874 @default.
- W4317526227 cites W2132592055 @default.
- W4317526227 doi "https://doi.org/10.22159/ajpcr.2023.v16i1.46967" @default.
- W4317526227 hasPublicationYear "2022" @default.
- W4317526227 type Work @default.
- W4317526227 citedByCount "0" @default.
- W4317526227 crossrefType "journal-article" @default.
- W4317526227 hasAuthorship W4317526227A5066566340 @default.
- W4317526227 hasAuthorship W4317526227A5085574543 @default.
- W4317526227 hasBestOaLocation W43175262271 @default.
- W4317526227 hasConcept C118552586 @default.
- W4317526227 hasConcept C126322002 @default.
- W4317526227 hasConcept C15744967 @default.
- W4317526227 hasConcept C173586616 @default.
- W4317526227 hasConcept C205044023 @default.
- W4317526227 hasConcept C2776175493 @default.
- W4317526227 hasConcept C2776412080 @default.
- W4317526227 hasConcept C2776619155 @default.
- W4317526227 hasConcept C2776921671 @default.
- W4317526227 hasConcept C2777765862 @default.
- W4317526227 hasConcept C2780035454 @default.
- W4317526227 hasConcept C2780494398 @default.
- W4317526227 hasConcept C42219234 @default.
- W4317526227 hasConcept C558461103 @default.
- W4317526227 hasConcept C71924100 @default.
- W4317526227 hasConcept C98274493 @default.
- W4317526227 hasConceptScore W4317526227C118552586 @default.
- W4317526227 hasConceptScore W4317526227C126322002 @default.
- W4317526227 hasConceptScore W4317526227C15744967 @default.
- W4317526227 hasConceptScore W4317526227C173586616 @default.
- W4317526227 hasConceptScore W4317526227C205044023 @default.
- W4317526227 hasConceptScore W4317526227C2776175493 @default.
- W4317526227 hasConceptScore W4317526227C2776412080 @default.
- W4317526227 hasConceptScore W4317526227C2776619155 @default.
- W4317526227 hasConceptScore W4317526227C2776921671 @default.
- W4317526227 hasConceptScore W4317526227C2777765862 @default.
- W4317526227 hasConceptScore W4317526227C2780035454 @default.
- W4317526227 hasConceptScore W4317526227C2780494398 @default.
- W4317526227 hasConceptScore W4317526227C42219234 @default.
- W4317526227 hasConceptScore W4317526227C558461103 @default.
- W4317526227 hasConceptScore W4317526227C71924100 @default.
- W4317526227 hasConceptScore W4317526227C98274493 @default.
- W4317526227 hasLocation W43175262271 @default.
- W4317526227 hasOpenAccess W4317526227 @default.
- W4317526227 hasPrimaryLocation W43175262271 @default.
- W4317526227 hasRelatedWork W1970660267 @default.
- W4317526227 hasRelatedWork W1988186839 @default.
- W4317526227 hasRelatedWork W2033332085 @default.
- W4317526227 hasRelatedWork W2042124981 @default.
- W4317526227 hasRelatedWork W2046267630 @default.
- W4317526227 hasRelatedWork W2065163198 @default.
- W4317526227 hasRelatedWork W2092953670 @default.
- W4317526227 hasRelatedWork W2122309493 @default.
- W4317526227 hasRelatedWork W2460042602 @default.
- W4317526227 hasRelatedWork W4317526227 @default.
- W4317526227 isParatext "false" @default.
- W4317526227 isRetracted "false" @default.
- W4317526227 workType "article" @default.